In vitro evaluation of HR810, a new wide-spectrum aminothiazolyl alpha-methoxyimino cephalosporin.
about
Antibacterial activities in vitro and in vivo and pharmacokinetics of cefquinome (HR 111V), a new broad-spectrum cephalosporinSusceptibilities of 177 penicillin-susceptible and -resistant pneumococci to FK 037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem, and vancomycin.Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens.Antimicrobial activity of HR810 against 419 strict anaerobic bacteria.In vitro activity of DQ-2556, a new cephalosporin.In vitro activity of BMY-28142 in comparison with those of other beta-lactam antimicrobial agents.Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporinIn vitro evaluation of Ro 09-1227, a novel catechol-substituted cephalosporinDistribution of cefpirome (HR 810) to exudate in the croton oil-induced rat granuloma pouch and its therapeutic effects on experimental infections in the pouch.Disk diffusion testing, quality control guidelines, and antimicrobial spectrum of HR810, a fourth-generation cephalosporin, in clinical microbiology laboratoriesIn vitro evaluation of GR69153, a novel catechol-substituted cephalosporin.Comparative study of pharmacokinetics and serum bactericidal activities of cefpirome, ceftazidime, ceftriaxone, imipenem, and ciprofloxacin.MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycin.Preliminary interpretive susceptibility testing criteria for FK-037 with 30-microgram disksTentative disk diffusion susceptibility interpretive criteria for BMY-28142, a new cephalosporin.Current trends and new perspectives in antibiotic therapy.TOC-39, a novel parenteral broad-spectrum cephalosporin with excellent activity against methicillin-resistant Staphylococcus aureusInteraction of cefpirome and a cephalosporinase from Citrobacter freundii GN7391.Microanalytical high-performance liquid chromatography assay for cefpirome (HR 810) in serum.In vitro activity of E-1040, a novel cephalosporin with potent activity against Pseudomonas aeruginosaComparative in vitro inhibitory and killing activity of cefpirome, ceftazidime, and cefotaxime against Pseudomonas aeruginosa, enterococci, Staphylococcus epidermidis, and methicillin-susceptible and -resistant and tolerant and nontolerant StaphylocBeta-lactamase stability of cefpirome (HR 810), a new cephalosporin with a broad antimicrobial spectrum.In vitro activity of FK037, a new parenteral cephalosporin, against anaerobic bacteria.In vitro and in vivo activities of DQ-2556 and its mode of action.In vitro antimicrobial activity of cefpirome against ceftazidime-resistant isolates from two multicenter studies.Comparative in vitro activity of cefpirome and cefepime, two new cephalosporins.The in vitro activity and beta-lactamase stability of cefpirome (HR 810), a pyridine cephalosporin agent active against staphylococci, Enterobacteriaceae and Pseudomonas aeruginosa.
P2860
Q33530773-5C2EFD33-EE57-4C9A-A609-30AC7FC81B46Q33753762-4088B7CD-A4AA-470E-892E-56B53248336CQ35570699-5A86EA8E-28F8-42CB-8457-3250D949C6A9Q35570837-20EC95D0-5121-43D0-85CD-C99CA4F78764Q35575411-BBDAA3F9-FC84-4AFA-B927-E8F800D50383Q35642311-F5A156D2-A706-4A74-8014-4A3168362E49Q35643730-461D0F8D-DDD9-44D3-815C-1AA429D6D455Q35844228-60BEB1CA-DC9B-4225-906E-31EEBE546000Q36438393-7C4DD408-098B-4068-AC25-10EC25E80206Q36608431-CA32F64F-585E-4218-A1A3-1EFECB4C531DQ36753812-27068B21-4240-4563-AF64-2C6DE043BA1BQ36757684-8CD639A4-F50F-462C-992A-4A12110BFAFEQ37115080-9FAA7BB2-AB4D-44ED-899F-D451D3103F04Q37166203-D7466BEA-850A-49B5-B88A-E810DF1BACB2Q37203973-6449EAE3-4D21-4137-89FA-2405319DDADEQ38725018-64F94D83-2E92-4CD0-B381-D093D726E979Q39779720-AEA5B462-767D-48A2-A778-4722FD6A8F46Q39815111-7830A66C-DAAD-43C9-BDE2-3DB2202B8F45Q39832448-6136FC88-4475-416D-AA08-938CB1A3171AQ39832633-C873D7BC-3D58-4112-B61C-8CF2F887C8A7Q39834183-0CC9500D-CD50-4B53-8869-E676DFA0DCDBQ39834956-DBF92FD8-E3E6-482F-8E05-AC296FCDACFCQ39865892-186E75AB-CE23-4310-839C-C7613BF7244CQ40088751-CD32EF0E-D9BC-4268-888F-8AA5F3B21CB9Q44580393-E8293374-5A43-4499-90FB-7BCDE86432E0Q44812759-16A07DAB-CA75-499F-97C4-DACBF266161AQ50205841-9ACBC2B2-912B-4A41-83C4-2880FACE8A90
P2860
In vitro evaluation of HR810, a new wide-spectrum aminothiazolyl alpha-methoxyimino cephalosporin.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
In vitro evaluation of HR810, ...... ha-methoxyimino cephalosporin.
@ast
In vitro evaluation of HR810, ...... ha-methoxyimino cephalosporin.
@en
type
label
In vitro evaluation of HR810, ...... ha-methoxyimino cephalosporin.
@ast
In vitro evaluation of HR810, ...... ha-methoxyimino cephalosporin.
@en
prefLabel
In vitro evaluation of HR810, ...... ha-methoxyimino cephalosporin.
@ast
In vitro evaluation of HR810, ...... ha-methoxyimino cephalosporin.
@en
P2093
P2860
P356
P1476
In vitro evaluation of HR810, ...... ha-methoxyimino cephalosporin.
@en
P2093
C Thornsberry
P2860
P304
P356
10.1128/AAC.25.6.710
P407
P577
1984-06-01T00:00:00Z